We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 31.4%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+31.4%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$865B
AUM Growth
-$62.5B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,208
New
Increased
Reduced
Closed

Top Buys

1 +$1.82B
2 +$1.38B
3 +$1.16B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
IR icon
Ingersoll Rand
IR
+$1.03B

Top Sells

1 +$4.73B
2 +$3.54B
3 +$1.75B
4
APH icon
Amphenol
APH
+$1.65B
5
KLAC icon
KLA
KLAC
+$1.5B

Sector Composition

1 Technology 33.6%
2 Financials 11.17%
3 Healthcare 11.1%
4 Communication Services 10.25%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGHT icon
3001
Sight Sciences
SGHT
$264M
$96K ﹤0.01%
25,283
EHTH icon
3002
eHealth
EHTH
$52.4M
$95K ﹤0.01%
73,336
+15,600
NVCT icon
3003
Nuvectis Pharma
NVCT
$260M
$94K ﹤0.01%
+12,048
FATE icon
3004
Fate Therapeutics
FATE
$221M
$92K ﹤0.01%
76,633
+22,163
NFE icon
3005
New Fortress Energy
NFE
$146M
$92K ﹤0.01%
154,547
+36,255
NNBR icon
3006
NN Inc
NNBR
$150M
$92K ﹤0.01%
63,163
SMHI icon
3007
SEACOR Marine Holdings
SMHI
$202M
$92K ﹤0.01%
12,764
PRTH icon
3008
Priority Technology Holdings
PRTH
$499M
$91K ﹤0.01%
19,248
+6,554
HRTX icon
3009
Heron Therapeutics
HRTX
$76.6M
$90K ﹤0.01%
111,504
+34,866
SKLZ icon
3010
Skillz
SKLZ
$138M
$89K ﹤0.01%
34,215
CURI icon
3011
CuriosityStream
CURI
$167M
$88K ﹤0.01%
29,683
+13,607
KLC
3012
KinderCare Learning Companies
KLC
$457M
$88K ﹤0.01%
39,733
+6,130
CCLD icon
3013
CareCloud
CCLD
$102M
$87K ﹤0.01%
23,700
LPRO icon
3014
Open Lending Corp
LPRO
$248M
$87K ﹤0.01%
69,287
+15,405
IKT icon
3015
Inhibikase Therapeutics
IKT
$220M
$86K ﹤0.01%
50,874
+20,268
LUCD icon
3016
Lucid Diagnostics
LUCD
$189M
$86K ﹤0.01%
74,377
+39,241
TLSI icon
3017
TriSalus Life Sciences
TLSI
$205M
$86K ﹤0.01%
21,294
+6,480
AOMR
3018
Angel Oak Mortgage REIT
AOMR
$208M
$85K ﹤0.01%
+10,222
CRDF icon
3019
Cardiff Oncology
CRDF
$105M
$85K ﹤0.01%
52,316
+20,986
CNTY icon
3020
Century Casinos
CNTY
$40M
$84K ﹤0.01%
59,831
CXDO icon
3021
Crexendo
CXDO
$221M
$84K ﹤0.01%
+13,545
AGEN
3022
Agenus
AGEN
$130M
$82K ﹤0.01%
24,500
PLCE icon
3023
Children's Place
PLCE
$80.2M
$80K ﹤0.01%
23,539
KSCP icon
3024
Knightscope
KSCP
$36.4M
$79K ﹤0.01%
18,900
LFVN icon
3025
LifeVantage
LFVN
$120M
$79K ﹤0.01%
18,234